Lion Tcr

Lion Tcr company information, Employees & Contact Information

Updated June 2026

Quick answer

Lion Tcr is a Biotechnology Research company. It has approximately 19 employees on record. Contact data was last refreshed in June 2026. Find Lion Tcr's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Lion Tcr email format Lion Tcr management contacts

Related company profiles:

External link for Lion TCR

Company Details

Employees
19
Address
2 Tukang Innovation Grove #09-04, Singapore,618305,singapore
Phone
+65 6586 9633
Email
in****@****tcr.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
liontcr.com
HQ
Singapore
Competitors
Zelluna, T-Cure Bioscience, Inc, Medigene AG, Alaunos Therapeutics, Tessa Therapeutics Ltd, Pan Cancer T, BlueSphere Bio, Neogene Therapeutics, Immatics, BioSyngen.
Looking for a particular Lion Tcr employee's phone or email?

Lion Tcr Questions

News

Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma - PR Newswire

Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma PR Newswire

The Formula Behind Lion TCR's Lifechanging Cancer Therapy. - Agency for Science, Technology and Research

The Formula Behind Lion TCR's Lifechanging Cancer Therapy. Agency for Science, Technology and Research

Lion TCR Announces FDA IND Clearance for its LioCyx-M004 for Hepatocellular Carcinoma - BioSpace

Lion TCR Announces FDA IND Clearance for its LioCyx-M004 for Hepatocellular Carcinoma BioSpace

Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations - The AI Journal

Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations The AI Journal

Immunotherapy company Lion TCR raises US$40 million in Series B2 funding - The Business Times

Immunotherapy company Lion TCR raises US$40 million in Series B2 funding The Business Times

Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy - PR Newswire

Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy PR Newswire

Companies like Lion Tcr

Neogene Therapeutics logo - Similar company to Lion Tcr

Neogene Therapeutics

61
Alaunos Therapeutics logo - Similar company to Lion Tcr

Alaunos Therapeutics

10
Tessa Therapeutics Ltd logo - Similar company to Lion Tcr

Tessa Therapeutics Ltd

40
Medigene AG logo - Similar company to Lion Tcr

Medigene Ag

88
Pan Cancer T logo - Similar company to Lion Tcr

Pan Cancer T

12
T-Cure Bioscience, Inc logo - Similar company to Lion Tcr

T-Cure Bioscience, Inc

4
Immatics logo - Similar company to Lion Tcr

Immatics

594
BioSyngen logo - Similar company to Lion Tcr

Biosyngen

23
BlueSphere Bio logo - Similar company to Lion Tcr

Bluesphere Bio

41
Zelluna logo - Similar company to Lion Tcr

Zelluna

30

Top Lion Tcr Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant